Skip to main content
. 2012 Oct 3;96(5):1129–1136. doi: 10.3945/ajcn.112.038125

TABLE 1.

Characteristics by TFC7L2 gene variant at baseline and changes in 6 mo and 2 y in participants in the Preventing Overweight Using Novel Dietary Strategies study1

rs7903146
rs12255372
CC CT TT P GG GT TT P
Full cohort [n (%)] 291 (49.5) 248 (42.2) 49 (8.3) 305 (51.6) 240 (40.6) 46 (7.8)
 Age (y) 52.5 ± 8.52 51.6 ± 9.5 51.6 ± 8.8 52.4 ± 8.9 51.4 ± 9.2 52.6 ± 8.4
 Sex (F) (%) 55.7 58.9 53.1 58.0 55.0 58.7
 Low-fat diet group (%) 47.4 52.8 40.8 46.9 52.5 45.7
 Low-protein group (%) 52.2 50.0 49.0 53.1 47.9 47.8
 Lowest-carbohydrate group (%) 25.4 23.4 30.6 24.6 24.6 30.4
 Center (Boston) (%) 47.8 47.6 42.9 45.3 49.2 41.3
 Weight (kg)
 Baseline 95.0 ± 0.7 94.8 ± 0.8 93.3 ± 1.8 0.450 94.8 ± 0.7 95.2 ± 0.8 90.8 ± 1.8 0.272
 6-mo change −6.3 ± 0.3 −6.9 ± 0.4 −7.0 ± 0.8 0.210 −6.3 ± 0.3 −6.9 ± 0.4 −7.3 ± 0.8 0.125
 2-y change −3.9 ± 0.4 −3.6 ± 0.5 −4.9 ± 1.0 0.760 −3.8 ± 0.4 −4.0 ± 0.5 −5.2 ± 1.1 0.360
 Waist circumference (cm)
 Baseline 105.2 ± 0.6 105.3 ± 0.7 104.5 ± 1.5 0.779 105.2 ± 0.6 105.5 ± 0.7 102.8 ± 1.6 0.420
 6-mo change −6.6 ± 0.4 −7.1 ± 0.4 −6.5 ± 0.9 0.563 −6.6 ± 0.4 −6.9 ± 0.4 −7.4 ± 0.9 0.350
 2-y change −4.8 ± 0.4 −4.8 ± 0.5 −5.4 ± 1.1 0.724 −4.8 ± 0.4 −5.0 ± 0.5 −6.1 ± 1.1 0.377
 BMI (kg/m2)
 Baseline 32.6 ± 0.2 32.7 ± 0.2 32.5 ± 0.5 0.914 32.5 ± 0.2 32.8 ± 0.2 32.1 ± 0.6 0.999
 6-mo change −2.2 ± 0.1 −2.4 ± 0.1 −2.4 ± 0.3 0.187 −2.2 ± 0.1 −2.4 ± 0.1 −2.5 ± 0.3 0.120
 2-y change −1.3 ± 0.2 −1.3 ± 0.2 −1.7 ± 0.4 0.670 −1.3 ± 0.1 −1.4 ± 0.2 −1.8 ± 0.4 0.350
DXA3 subset [n (%)] 159 (49.3) 136 (42.2) 27 (8.4) 162 (49.7) 135 (41.4) 29 (8.9)
 Total fat mass (%)
 Baseline 36.2 ± 0.3 36.6 ± 0.4 37.1 ± 0.8 0.258 36.1 ± 0.3 36.9 ± 0.4 37.1 ± 0.8 0.073
 6-mo change −2.9 ± 0.3 −3.3 ± 0.3 −3.4 ± 0.6 0.364 −3.0 ± 0.3 −3.2 ± 0.3 −3.5 ± 0.6 0.449
 2-y change −2.4 ± 0.4 −2.3 ± 0.4 −1.8 ± 0.8 0.583 −2.5 ± 0.4 −2.3 ± 0.4 −2.5 ± 0.8 0.904
 Lean mass (kg)
 Baseline 61.1 ± 0.5 61.4 ± 0.6 58.6 ± 1.2 0.256 61.1 ± 0.5 61.7 ± 0.5 57.1 ± 1.2 0.100
 6-mo change −2.3 ± 0.2 −2.3 ± 0.2 −2.0 ± 0.4 0.615 −2.3 ± 0.2 −2.3 ± 0.2 −2.3 ± 0.4 0.976
 2-y change −2.3 ± 0.3 −1.9 ± 0.3 −2.4 ± 0.7 0.601 −2.2 ± 0.3 −2.0 ± 0.3 −2.5 ± 0.7 0.987
 Trunk fat (%)
 Baseline 37.2 ± 0.4 37.9 ± 0.4 38.3 ± 0.9 0.116 37.1 ± 0.4 38.3 ± 0.4 38.2 ± 0.9 0.050
 6-mo change −3.7 ± 0.3 −4.3 ± 0.4 −4.0 ± 0.8 0.496 −3.9 ± 0.3 −4.2 ± 0.4 −4.0 ± 0.8 0.662
 2-y change −3.1 ± 0.5 −3.2 ± 0.5 −2.0 ± 1.1 0.512 −3.3 ± 0.5 −3.1 ± 0.5 −2.9 ± 1.0 0.707
1

Linear mixed models were used to determine mean baseline outcome measures adjusted for age, sex, and center and 6-mo and 2-y changes adjusted for age, sex, center, baseline measure, and diet intervention. Macronutrients from 4 randomized intervention diets were dichotomized as follows: low fat (2 diets with a target for total fat of 20% from total energy) compared with high fat (2 diets with a target for total fat of 40% from total energy); low protein (2 diets with a target of 15% from energy) compared with high protein (2 diets with a target of 25% from energy); and low carbohydrate (one diet with the lowest carbohydrate composition of 35% from energy) compared with high carbohydrate (one diet with a carbohydrate composition of 65%).

2

Mean ± SD (all such values).

3

DXA, dual-energy X-ray absorptiometry.

HHS Vulnerability Disclosure